| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 52,87% | 25,14% | -19,62% | · |
| SCHRODER ISF EMERGING ASIA IZ ACC USD | RVI ASIA PACÍFICO | 52,87% | 75,11% | 49,08% | 227,83% |
| ROBECO ASIA-PACIFIC EQUITIES F EUR | RVI ASIA PACÍFICO | 52,86% | 91,66% | 94,28% | 191,83% |
| BGF EMERGING MARKETS X2 AUD | RVI EMERGENTES | 52,83% | 63,01% | · | · |
| NOMURA FUNDS IRELAND - AMERICAN CENTURY EMERGING MARKETS EQUITY FUND I USD | RVI EMERGENTES | 52,81% | 88,53% | 39,92% | · |
| CT (LUX) ASIA EQUITIES 2U USD | RVI ASIA EX-JAPÓN | 52,80% | 80,04% | 36,12% | · |
| FIDELITY FUNDS-TECHNOLOGY OPPORTUNITIES Y-ACC-EUR | RVI TECNOLOGÍA | 52,80% | 85,56% | 51,94% | · |
| FIDELITY FUNDS-TECHNOLOGY OPPORTUNITIES Y-DIST-EUR | RVI TECNOLOGÍA | 52,80% | 85,63% | 51,93% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 52,80% | 24,74% | -19,79% | · |
| SCHRODER ISF CHINA A C ACC GBP | RVI CHINA | 52,78% | 40,83% | · | · |
